Cargando…
Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid
Despite the development of treatment options in breast cancer, many patients die of recurrence and metastasis. Owing to enhanced permeability and retention in solid tumor tissue, nanoparticle (NP) delivery systems have been emerged as novel strategy in cancer chemotherapy. As extracellular matrix, g...
Autores principales: | Wang, Qin, Zhong, Yinan, Liu, Wenting, Wang, Zemin, Gu, Liqin, Li, Xuejiao, Zheng, Jiqing, Du, Huan, Zhong, Zhiyuan, Xie, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352940/ https://www.ncbi.nlm.nih.gov/pubmed/30691317 http://dx.doi.org/10.1080/10717544.2018.1507057 |
Ejemplares similares
-
Targeted inhibition of human hematological cancers in vivo by doxorubicin encapsulated in smart lipoic acid-crosslinked hyaluronic acid nanoparticles
por: Zhong, Yinan, et al.
Publicado: (2017) -
Endosomal pH-Responsive Fe-Based Hyaluronate Nanoparticles for Doxorubicin Delivery
por: Bae, Yangmun, et al.
Publicado: (2021) -
Hyaluronic Acid-Modified and Doxorubicin-Loaded Gold Nanoparticles and Evaluation of Their Bioactivity
por: Li, Lin-Song, et al.
Publicado: (2021) -
Statistical Optimization of Hydrazone-Crosslinked Hyaluronic Acid Hydrogels for Protein Delivery
por: Mozipo, Esther A., et al.
Publicado: (2023) -
Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer
por: Liang, Ye, et al.
Publicado: (2020)